Menu
This report by the Lancet Commission on Public Policy and Health in the Trump Era assesses the repercussions of President Donald Trump’s health-related policies and examines the failures and social schisms that enabled his election.
The COVID-19 pandemic placed a heavy weight on a trillion-dollar global pharmaceutical industry already struggling under the opioid crisis and pricing controversies. Although the drug development process typically takes ten or more years, the urgency of COVID-19 forced government regulators to shed tradition for flexibility.
The pandemic has revealed a schism between progressive Democrats and moderates, wrestling with the needs of hard-hit businesses and working parents and caregivers.
With stimulus talks with Congress at an impasse, President Donald Trump signed a series of executive orders on Saturday to provide temporary relief to Americans who are suffering from the economic impact of the coronavirus pandemic.
Over the weekend, President Donald Trump issued several new executive orders aimed at extending the Covid-19 economic stimulus that has offered some financial relief to millions of Americans. But instead of bringing clarity, the orders have generated a raft of confusion. Are they even constitutional? Will they go into effect?
A “CEO tax” targeting San Francisco’s most unequal salaries. A signature-gathering campaign to tax Palo Alto’s millionaires. And now, a new statewide bill that would levy a yearly 0.4 percent tax on every Californian worth more than $30 million.
Five weeks after Gov. Gavin Newsom ordered Californians to stay at home to slow the spread of the coronavirus, protesters gathered at the state Capitol to call for easing restrictions and lawmakers complained they haven’t had a voice in managing the crisis.
How should California dig itself out of a $54 billion deficit? A divide between state lawmakers over how to generate revenue mirrors a national reckoning in Democratic politics.
